160880-98-8

Basic information

• Product Name: N-Boc-L-aspartyl(benzyl)-3-(aminomethyl)benzoic acid
• Synonyms: N-Boc-L-aspartyl(benzyl)-3-(aminomethyl)benzoic acid
• CAS NO: 160880-98-8
• Molecular Weight: 456.496
• Mol File: 160880-98-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-Boc-L-aspartyl(benzyl)-3-(aminomethyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-L-aspartyl(benzyl)-3-(aminomethyl)benzoic acid(160880-98-8)
• EPA Substance Registry System: N-Boc-L-aspartyl(benzyl)-3-(aminomethyl)benzoic acid(160880-98-8)

Safety Data

• Hazardous Substances Data: 160880-98-8(Hazardous Substances Data)

Upstream product

• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 2393-20-6 3-aminomethylbenzoic acid 
• 13798-75-9 N^α-t-butoxycarbonylaspartic acid α-N-hydroxysuccinimide ester β-benzyl ester 

Downstream Products

• 167215-29-4 C₄₈H₆₂F₃N₉O₁₃S 
• 167215-31-8 C₄₃H₅₂F₃N₉O₁₀S 
• 755729-53-4 C₄₃H₅₄F₃N₉O₁₁S 
• 182345-06-8 3-[((S)-2-Amino-3-benzyloxycarbonyl-propionylamino)-methyl]-benzoic acid 

Relevant articles and documents

Tc-99m-labeled fibrinogen receptor antagonists: Design and synthesis of cyclic RGD peptides for the detection of thrombi

Tc-99m labeled derivatives of N-Me-Arg-Gly-Asp containing cyclic peptide GP IIb/IIIa receptor antagonists are potential radiopharmaceuticals for the diagnosis of thrombosis. The design and synthesis of these peptides are described. These compounds are incorporated in rapidly growing thrombi under both arterial and venous conditions in canine models. Thrombi are clearly visible in images acquired at 50 min.